ARCHIVES

Nader Group Backs FDA In controversy Over Drug Testing

This article is from The Cancer Letter archive.

Vol. 03 No. 06 | February 11, 1977

Download PDF Visit The Full Archive

Related Articles

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007

Troubled Allegheny Cuts Cancer Programs; Institution Holds Grants for NSABP, ECOG

July 10, 1998

L-PAM Benefit To Post-Menopausal Patients Challenged

October 29, 1976

In Brief: Freireich On Nutrition: Diet Can Affect Immune System, Effectiveness Of Cancer Drugs

September 12, 1975

Citizens Committee Notes Broad Support For NCI Funds

August 24, 1979

Consolidation Unlikely to Save Money

December 17, 2010